retatrutide clinical trials review trial results 2024 2025 press release A of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Lilly's triple agonist, retatrutide, delivered – AllWell - Everyone keeps asking

US$ 23.17

★★★★★ 4.8 (17 reviews)

US$ 25.63

★★★★★ 4.6 (17 reviews)

US$ 25.56

★★★★★ 4.2 (29 reviews)

US$ 23.29

★★★★★ 4.3 (23 reviews)

US$ 20.39

★★★★★ 4.6 (16 reviews)

US$ 26.99

★★★★★ 4.2 (26 reviews)

US$ 23.68

★★★★★ 4.4 (26 reviews)

US$ 20.97

★★★★★ 4.5 (16 reviews)

US$ 22.51

★★★★★ 4.0 (11 reviews)

US$ 21.99

★★★★★ 4.0 (19 reviews)

US$ 28.11

★★★★★ 4.9 (16 reviews)

US$ 23.39

★★★★★ 4.3 (28 reviews)

US$ 24.71

★★★★★ 4.6 (8 reviews)

US$ 24.94

★★★★★ 4.7 (19 reviews)

US$ 26.42

★★★★★ 4.6 (22 reviews)

US$ 25.60

★★★★★ 4.2 (24 reviews)

US$ 27.15

★★★★★ 4.9 (25 reviews)

US$ 28.75

★★★★★ 4.8 (23 reviews)

US$ 29.25

★★★★★ 4.8 (9 reviews)

US$ 22.48

★★★★★ 4.6 (16 reviews)